Cryptogenic Organizing Pneumonia: Serial High-Resolution CT Findings in 22 Patients
|
|
- Tobias Hart
- 6 years ago
- Views:
Transcription
1 Cardiopulmonary Imaging Original Research Lee et al. High-Resolution CT of Cryptogenic Organizing Pneumonia Cardiopulmonary Imaging Original Research Ju Won Lee 1 Kyung Soo Lee 1 Ho Yun Lee 1 Man Pyo Chung 2 Chin A Yi 1 Tae Sung Kim 1 Myung Jin Chung 1 Lee JW, Lee KS, Lee HY, et al. Keywords: cryptogenic organizing pneumonia, lung CT, lung interstitial disease DOI: /AJR Received November 9, 2009; accepted after revision February 28, Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-Dong, Kangnam-Ku, Seoul , Republic of Korea. Address correspondence to K. S. Lee (kyungs.lee@samsung.com). 2 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. AJR 2010; 195: X/10/ American Roentgen Ray Society Cryptogenic Organizing Pneumonia: Serial High-Resolution CT Findings in 22 Patients OBJECTIVE. We conducted a review of serial high-resolution CT (HRCT) findings of cryptogenic organizing pneumonia (COP). MATERIALS AND METHODS. Over the course of 14 years, we saw 32 patients with biopsy-confirmed COP. Serial HRCT scans were available for only 22 patients (seven men and 15 women; mean age, 52 years; median follow-up period, 8 months; range, months). Serial CT scans were evaluated by two chest radiologists who reached a conclusion by consensus. Overall changes in disease extent were classified as cured, improved (i.e., 10% decrease in extent), not changed, or progressed (i.e., 10% increase in extent). When there were remaining abnormalities, the final follow-up CT images were analyzed to express observers ideas regarding what type of interstitial lung disease the images most likely suggested. RESULTS. The two most common patterns of lung abnormality on initial scans were ground-glass opacification (86% of patients [19/22]) and consolidation (77% of patients [17/22]), distributed along the bronchovascular bundles or subpleural lungs in 13 patients (59%). In six patients (27%), the disease disappeared completely; in 15 patients (68%), the disease was decreased in extent; and in one patient (5%), no change in extent was detected on follow-up CT. When lesions remained, the final follow-up CT findings were reminiscent of fibrotic nonspecific interstitial pneumonia in 10 of 16 patients (63%). CONCLUSION. Although COP is a disease with a generally good prognosis, most patients (73%) with COP have some remaining disease seen on follow-up CT scans, and, in such cases, the lesions generally resemble a fibrotic nonspecific interstitial pneumonia pattern. C ryptogenic organizing pneumonia (COP) is characterized histopathologically by plugs of granulation tissue lying within small airways, alveolar ducts, and alveoli and by chronic inflammatory cell infiltration in alveolar walls [1]. Patients with COP generally present with subacute illness, including shortness of breath, fever, malaise, and weight loss [1, 2]. Imaging findings of COP at presentation have been well characterized. Common chest radiographic findings include bilateral patchy areas of consolidation showing subpleural and lower lung zone predominance. High-resolution CT (HRCT) findings consist of consolidative areas or nodules distributed along the bronchovascular bundles or along the subpleural lungs [3 6]. Patients with COP manifest good prognoses with corticosteroid therapy [2]. However, despite this therapy, cases of relapse or progression have been reported [7, 8]. In addi- tion, in rare cases, a disease initially identified as COP progresses to respiratory failure and death [9]. Thus, more studies as to the exact clinical outcome of COP, particularly dealing with large number of patients, are needed. Moreover, to the best of our knowledge, the follow-up HRCT findings of the disease in a large patient cohort have yet to be reported. Thus, the principal objective of our study was to report serial HRCT findings of COP in a relatively large patient population and to look for clinical, pulmonary function test (PFT), or HRCT findings that might facilitate the prediction of patient prognoses. Materials and Methods Patient Enrollment and Demographics Our institutional review board approved this retrospective study with a waiver of patient informed consent. We reviewed all surgical biopsy files recorded from January 1995 to May 2008 in a single tertiary hospital and identified 72 patients who had a histopathologic diagnosis of organizing 916 AJR:195, October 2010
2 High-Resolution CT of Cryptogenic Organizing Pneumonia pneumonia. Among the 72 patients, 16 patients had underlying collagen vascular disease, 14 patients had concurrent pulmonary infection, and 10 had drug-associated lung diseases. We excluded these 40 patients from this study. Therefore, the remaining 32 patients had a histopathologic diagnosis of organizing pneumonia of unknown cause (i.e., COP). Among these 32 patients, 10 had received no follow-up CT or follow-up examination only within a 1-month interval. None of these 10 patients died of COP. For the remaining 22 patients, follow-up CT studies were obtained at least once, and the shortest follow-up period was 2 months. Thus, a total of 22 patients with COP (seven men and 15 women; mean [± SD] age, 52 ± 11.2 years; range, years) were ultimately included in this study. The serial HRCT scans were obtained over a mean follow-up period of 18 ± 29.6 months (median, 7 months; range, months). All patients underwent surgical lung biopsies (video-assisted thoracoscopic surgery biopsy, n = 21; open lung biopsy, n = 1). Surgical lung biopsy specimens were acquired from three lobes in two patients, from two lobes in 11 patients, and from one lobe in nine patients. PFT Initial PFT data were obtained for 19 patients. Forced spirometry and single-breath carbon monoxide diffusing capacity of the lung (DL CO ) were obtained with pulmonary function units (V max 22, SensorMedics Corporation). Forced vital capacity (FVC) and DL CO were expressed as a percentage of the predicted value based on height, age, sex, and ethnic origin. Additionally, arterial oxygen tension at room air (PaO 2 ) was measured at the time of biopsy or when PFT results were obtained. Serial trends in PFT results and PaO 2 values at follow-up studies were defined as improvement (i.e., an increase of > 15% in FVC or DL CO or an increase of > 15 mm Hg in PaO 2 ), decline (i.e., a decrease of > 15% in FVC or DL CO or a decrease of > 15 mm Hg in PaO 2 ), or stability (i.e., a change of < 15% in FVC or DL CO or a change of < 15 mm Hg in PaO 2 ). Image Acquisition Twenty-two patients underwent a total of 80 HRCT studies (mean, 3.6 ± 1.8 CT examinations per patient; range, 2 9 CT examinations). For the total of 44 CT studies performed for 22 patients as the initial and final follow-up scans, various helical CT scanners from different vendor companies with various numbers of detectors were used for CT image acquisition. A single-detector scanner was used for 17 studies, a 4-MDCT scanner was used for six studies, an 8-MDCT scanner was used for six studies, a 16-MDCT scanner was used for nine studies, a 40-MDCT scanner was used for two studies, and a 64-MDCT scanner was used for four studies. None of the patients received IV injections of contrast medium for the CT study. The scanning parameters were 120 kvp and ma. With MDCT scanners, helical CT scans (beam width of mm and beam pitch of ) were obtained throughout the thorax, and the scan data were reconstructed with mm section thickness and at 10-mm intervals, covering from the lung apices to the bottom of the lungs. With a single-detector scanner, 1.0-mm high-resolution lung-window CT images were obtained throughout the thorax at 10-mm TABLE 1: Clinical and Physiologic Analysis Results in 22 Patients With Biopsy-Proved Cryptogenic Organizing Pneumonia Clinical Result Initial Follow-Up Men, no. (%) of patients 7 (32) NA Smokers, no. (%) of patients 5 (23) NA Age at diagnosis (y) 52 ± 11.2 NA Duration from onset of symptom to treatment (mo) 4 NA Physiologic Forced vital capacity (% of predicted value) a 70 ± 21.6 a 85 ± 22.4 a Single-breath carbon monoxide diffusing capacity of the lung 75 ± 18.2 b 86.3 ± 3.9 c (% of predicted value) b Arterial oxygen tension at room air (mm Hg) d 80 ± 16.5 d 93 ± 9.4 e Note Except where noted, data are mean ± SD. NA = not applicable. a Data were available for 19 patients. b Data were available for 13 patients. c Data were available for 11 patients. d Data were available for 15 patients. e Data were available for 9 patients. intervals. In both single-detector CT and MDCT, data were reconstructed by using a bone algorithm. Image data were displayed directly on the monitors (four monitors with 1,536 2,048 image matrices, 8-bit viewable gray-scale, and 60-foot-lambert luminescence) of a PACS (PathSpeed or Centricity 2.0; GE Healthcare Integrated Imaging Solutions). Both mediastinal (window width, 400 HU; window level, 20 HU) and lung (window width, 1,500 HU; window level, 700 HU) window images were available for analysis on the monitors. Analyses of Thin-Section CT Findings Patterns (consolidation, ground-glass opacification [GGO], nodule, reticulation, and honeycombing), extent (to the nearest 5%), and distribution of lung abnormalities at the initial and final followup CT scan were evaluated by two chest radiologists with 5 and 20 years of experience in thoracic CT interpretation, respectively, who reached their conclusions by consensus. Overall disease extent changes were evaluated by comparing the initial and the final follow-up CT scans [10], and then the changes were divided into the following categories: completely resolved, improved (i.e., 10% decrease in total extent), not changed, and progressed (i.e., 10% increase in extent). In cases of complete disappearance, the follow-up interval was defined as period between the initial CT and the first follow-up CT that showed completely resolved parenchymal lesions. After the estimation of lung lesion extent, the final follow-up CT images were given again to the same two observers, who were asked to express their ideas independently as to what disease the given images most suggested (i.e., COP, nonspecific interstitial pneumonia [NSIP], or usual interstitial pneumonia [UIP]), according to previously published CT findings of idiopathic interstitial pneumonias [2]. When there was disagreement regarding which residual pattern the interstitial lung disease on follow-up CT scans suggested, the final decision was arrived at by consensus. The presence of pleural effusion, pleural thickening, pericardial effusion, and lymphadenopathy were also recorded. Clinical Outcome of Patients We reviewed the patients medical records. Relevant data included clinical symptoms at initial presentation, time interval between onset of symptom and treatment, treatment regimens, and relapse and survival of the patients. Relapses of COP were defined as the appearance of new characteristic opacities on chest imaging, with compatible clinical features, after some period of stable or improved state. Patients survival was identified from medical records or by contacting the patient s family when necessary. AJR:195, October
3 Lee et al. Statistical Analysis Statistical analyses were conducted by using SPSS software (version 12.0, SPSS, Inc.). The relationship between the changes in serial CT findings (patients with completely disappeared disease and with remaining disease) and the initial PFT or CT finding results was correlated. Univariate and multivariate analyses were conducted to seek clinical information or initial CT findings that would help to predict remaining disease on follow-up CT. Continuous data were compared between the complete resolution group and the remaining disease group by using the Mann-Whitney U test, and categorical data were compared by using Fisher s exact test. In all statistical analyses, p values less than 0.05 were considered statistically significant. Results The demographic and clinical findings of 22 patients with biopsy-confirmed COP are summarized in Table 1. All 22 patients presented with dyspnea, cough, or fever. Seventeen patients were nonsmokers, three were ex-smokers (mean duration, 19 pack-years), and two were smokers (mean duration, 33 pack-years). PFT Results PFT results are also summarized in Table 1. Among 19 patients for whom FVC results (percentage of predicted value) was available, an interval increase was noted in 11 patients (58%), and stability was noted in eight patients (42%) on follow-up examinations. None of the patients exhibited an interval decrease in FVC. Eleven patients had both TABLE 2: Initial and Follow-Up CT Patterns, Distribution, and Extent of Lung Involvement in 22 Patients With Cryptogenic Organizing Pneumonia Pattern Parameter No. (%) of Patients initial and follow-up DL CO examinations. Six patients (55%) were deemed stable, five patients (45%) had an interval increase, and none exhibited an interval decrease on follow-up DL CO examinations. Initial PaO 2 results were available for 15 patients. The mean PaO 2 was 80 ± 16.5 mm Hg. Nine patients had both initial and follow-up PaO 2. Three patients (33%) were stable, six patients (67%) showed an interval increase, and none exhibited an interval decrease on follow-up PaO 2 examinations. Serial Thin-Section CT Findings The initial and follow-up CT scan findings are summarized in Table 2. The two most Initial CT Average Extent (%) No. (%) of Patients Follow-Up CT Average Extent (%) Consolidation 17 (77) 27 1 (5) 20 Ground-glass opacification 19 (86) (72) 21 Nodule 7 (32) 10 1 (5) 10 Reticulation 4 (18) (50) 12 Honeycombing (9) 8 Distribution Lower lung predominance 12 (55) NA 10 (45) NA Subpleural 9 (41) NA 8 (36) NA Peribronchovascular 5 (23) NA 4 (18) NA Note NA = not applicable. A common patterns of lung abnormality on the initial scans were GGO (observed in 19 patients [86%]) and consolidation (observed in 17 patients [77%]), and they were distributed along the bronchovascular bundles or subpleural lungs in 13 (59%) of 22 patients. All initial scans showed lung abnormality in the lower lobes, and lower lobe predominance was noted in 12 patients (55%). Pleural effusion and subcarinal lymphadenopathy were detected in one patient each. Pericardial effusion was not detected in any patient. On the follow-up CT scans, the disease disappeared completely in six of 22 patients (27%) (Fig. 1), 15 (68%) showed a decrease in disease severity (Figs. 2 and 3), one (5%) Fig year-old woman with cryptogenic organizing pneumonia showing complete resolution on follow-up CT scans. A, Transverse thin-section (1.0-mm section thickness) CT scan obtained at level of basal segmental bronchi shows bilateral patchy ground-glass opacification (GGO) lesions distributed along bronchovascular bundles in lower lung zones. Linear consolidation surrounds internal GGO, so-called reversed halo sign (arrows), in right lower lobe. There was no parenchymal opacity in upper and middle lung zones (not shown here). Total extent of parenchymal abnormalities on CT scans was 20% (consolidation, 10%; GGO, 10%). B, Nine-month follow-up CT scan obtained at similar level to panel A shows complete resolution of lung lesions without remaining disease. B 918 AJR:195, October 2010
4 High-Resolution CT of Cryptogenic Organizing Pneumonia showed no change in disease extent, and none of the patients exhibited interval progression. The mean follow-up period for the patients whose disease had completely disappeared was 6 ± 2.3 months (range, 2 9 months), and that for the patients with remaining disease was 23 ± 33.6 months (range, months). The most common CT findings on follow-up CT scans were GGO (observed in 16 patients [73%]), followed by reticulation (observed in 11 patients [50%]). Among the 16 (73%) patients who had remaining disease on follow-up CT scans, 10 patients (63%) showed a pattern of lung abnormalities most similar to that of fibrotic NSIP (Fig. 2). The principal findings were GGO and reticulation involving predominantly subpleural and basal lungs. Traction bronchiectasis was noted in two of these 10 patients. The 10 patients exhibited neither consolidation nor honeycombing. In two patients (13%), CT findings composed by only GGO without any predominance in distribution, although nonspecific, reminded the observer of hypersensitivity pneumonitis. In another two patients (13%), honeycombing with lower lung zone predominance was noted; thus, the CT findings were most similar to the UIP pattern (Fig. 3). Traction bronchiectasis was also present in these two patients. One patient each (6%) showed a cellular NSIP pattern (subpleural and lower lung zone predominant GGO, with little reticulation and without traction bronchiectasis) and residual COP pattern on their followup CT scans, in the opinion of the reviewers. A Fig year-old woman with cryptogenic organizing pneumonia showing improvement but remaining disease. A, Transverse thin-section (1.0-mm section thickness) CT scan obtained at level of liver dome shows bilateral patchy areas of consolidation and nodules distributed along bronchovascular bundles in lower lung zones. Total extent of parenchymal abnormalities on CT scans was 50% (consolidation, 40%; nodule, 10%). B, Nine-month follow-up CT scan obtained at similar level to panel A shows decreased extent of parenchymal lesions. Total extent of remaining lung lesions was 30% (ground-glass opacification, 20%; reticulation, 10%). Note associated traction bronchiectasis (arrows) in both lower lobes. Remaining abnormalities are suggestive of fibrotic nonspecific interstitial pneumonia. In the last case, in which the residual disease was finally classified as cellular NSIP, the two observers had different ideas about the remaining lesion pattern one classified it as continuing COP, and the other classified it as cellular NSIP pattern. Clinical Outcomes of Patients All 22 patients had begun a course of corticosteroid treatment a median of 3 months (range, 1 24 months) from symptom onset. Two of 22 patients (9%) had clinically recurring COP. Both of the patients survived, and their final follow-up periods were 147 and 72 months, respectively. In the former patient, follow-up CT scans obtained 135 months after the initial scan revealed several new subpleural nodular lesions in both upper lobes, in addition to the usual interstitial pneumonialike fibrosis in the middle and lower lung zones. The latter patient was deemed cured on the final available follow-up CT scans. Afterward, the patient had several episodes of relapse and exhibited an interval increase in the extent of bilateral parenchymal opacities, with lower lung zone predominance on the final follow-up chest radiographs. Six patients were lost to clinical long-term follow-up, and the remaining 16 patients were still surviving. None of the patients died of COP, or for any other reason. Interrelationship Between Imaging and Laboratory Findings Neither clinical information nor the pattern of parenchymal abnormalities on the initial CT scans differed significantly between the two groups (patients with complete disappearance of lung lesions on follow-up CT [n = 6] and with remaining lung abnormalities [n = 16]; p > 0.05). None of the variables on the initial CT findings helped to predict the follow-up CT finding results (Table 3). The initial FVC (percentage of predicted value) and initial DL CO (percentage of predicted value) results for patients with completely resolved disease were significantly higher than those of patients with remaining disease (p < 0.05) (Table 3). Discussion It has been shown that most patients who respond to corticosteroids show complete clearing or are left with small residual opacities [2]. If reticular opacities are the initial radiographic findings in patients with COP, the patient is less likely to respond to corticosteroids and may progress to lung fibrosis [11]. In our study, four patients exhibited reticulation on their initial CT images. These four patients had remaining diseases on their followup CT scans (mean follow-up period, 15 months; range, 5 55 months), three patients exhibited decreased extent of abnormalities, and one patient manifested unchanged disease extent. However, unlike a previous study [11], in the present study, the pattern of parenchymal abnormalities on the initial CT scans clearly did not constitute a prognosis-determining factor on a univariate or multivariate analysis. We cannot explain the difference in results between the previous study and ours. B AJR:195, October
5 Lee et al. In the previous study [11], the results were based on chest radiographic finding analyses, not on CT examination results, as in ours. In addition, in both studies, the number of patients included was small. In our study, six patients (27%) had entered complete remission on follow-up CT examination. To the best of our knowledge, there has been no study thus far regarding the follow-up CT findings in COP. In a previous study [12], 24 of 50 patients (48%) manifested completely normal follow-up chest radiographs. In another study dealing with 12 immunocompromised patients with organizing pneumonia [13], five patients (42%) A C E Fig year-old man with cryptogenic organizing pneumonia showing decrease in total extent of disease (improvement) but remaining disease. A C, Transverse thin-section (1.0-mm section thickness) CT scans obtained at levels of trachea (A), superior segmental bronchi of lower lobes (B), and liver dome (C), respectively, show bilateral consolidation, ground-glass opacification (GGO), and nodules of lower lung zone and subpleural distribution. Total extent of parenchymal abnormalities on CT scans were 70% (consolidation, 40%; GGO, 20%; nodules, 10%). D F, Follow-up CT scans (135 months) obtained at similar levels to panels A, B, and C, respectively, show decreased extent of parenchymal lesions. Total extent of remaining lesions was 40% (GGO, 20%; reticulation, 10%; honeycombing [arrows], 10%). Remaining abnormalities show subpleural and lower lung zone predominance and simulate usual interstitial pneumonia pattern. B D F 920 AJR:195, October 2010
6 High-Resolution CT of Cryptogenic Organizing Pneumonia TABLE 3: Comparison of Clinical, Imaging, and Pulmonary Function Test Findings Between Patients With Complete Disappearance and Remaining Disease Clinical information Parameter exhibited complete resolution in follow-up radiographs obtained at a mean of 15 weeks. Of the 12 patients, four had available followup CT scans, and all four patients had remaining disease as shown by such findings as focal reticulation, nodules, consolidation, or GGO. There were two patients (9%) in our study whose follow-up clinical status showed some progression of disease after the stable period, which is suggestive of relapse. One patient showed no change in the extent of parenchymal opacity between the initial and final follow-up radiographs. The other patient had a slightly increased extent of parenchymal opacity between the initial and final follow-up radiographs. The proportion (9%) of relapsed COP cases in the current study is comparable to that reported in some previous studies [9, 14]. However, in the other studies, more than half of the patients with COP had relapsed disease [7, 15]. Largerscale and prospective studies will be required to search for relapse rates and to detect any correlation between relapse and remaining disease on follow-up CT scans. In 10 patients (63% of 16 patients who had remaining disease), the findings of follow-up CT scans reminded the observers of fibrotic Patients With Complete Disappearance (n = 6) NSIP. The principal findings indicated that the remaining diseases were GGO and reticulation, predominantly involving the subpleural or basal lungs. The findings revealed neither consolidations nor honeycombing. It is interesting to note that the remaining lung findings of COP, even after corticosteroid treatment, mimic those of fibrotic NSIP. To the best of our knowledge, this is the first report to specifically address the follow-up CT findings. It is important, however, to note that the follow-up assessments were based only on the experienced observers best estimate of the CT pattern. Radiologic-pathologic correlation would be necessary to confirm these opinions regarding treated patients with COP. It should also be elaborated that the imaging findings of NSIP are diverse [16, 17]. The patterns of lung abnormalities in NSIP range from consolidation or GGO to reticulation. Therefore, the similarities between the CT findings of residual COP and NSIP may not be unexpected news. Moreover, there is potential difficulty in separating COP and NSIP histopathologically [18]. Because half of NSIP biopsy specimens contain areas of organizing pneumonia component at the time of diagnosis, it may be possible Patients With Remaining Disease (n = 16) Men, no. (%) of patients 1 (17) 6 (38) Smokers, no. (%) of patients 1 (17) 4 (25) Age (y) 50 ± ± Duration from onset of symptom to treatment (mos) 5 ± ± CT findings Total extent (%) 45 ± ± Consolidation (%) 13 ± ± Ground-glass opacification (%) 28 ± ± Nodule (%) 3 ± ± Reticulation (%) 0 3 ± Honeycombing (%) Pulmonary function test findings Forced vital capacity (% of predicted value) 93 ± ± 16.2 a b Single-breath carbon monoxide diffusing capacity of the lung (% of predicted value) 86 ± ± 14.2 c b Arterial oxygen tension at room air (mm Hg) 88 ± 12.6 d 76 ± 17.0 e Note Except where noted, data are mean ± SD. a Data were available for 13 patients. b Statistically significant. c Data were available for seven patients. d Data were available for four patients. e Data were available for 11 patients. that some of the cases of COP in our series might have been misdiagnosed and may, in fact, have represented NSIP. To our knowledge, there have been no studies thus far conducted in which a correlation was drawn between the physiologic data and the follow-up CT results. In one study [7], no significant difference was detected between nonrelapsing and relapsing groups in terms of PFT results. In our study, the initial FVC and initial DL co values of patients with completely resolved disease were significantly higher than those for patients with remaining disease. Additionally, one important finding on PFT results is that, although several patients had fibrotic pattern of NSIP on follow-up HRCT scans, there was no evidence of any crucial decline in pulmonary function. This study has some limitations. First, the study design was retrospective. Second, the number of patients included in the study was rather small. Only 22 of the original 32 patients with biopsy-proven COP were included in the study. The remaining 10 patients did not have follow-up CT examinations. This may have introduced a major bias into the investigation, because those patients who did not undergo follow-up CT examinations p AJR:195, October
7 Lee et al. may have done extremely well clinically and may not have had residual disease. Third, the follow-up intervals varied, with the shortest follow-up period being only 2 months, and this may have affected the relapse data [7]. In conclusion, although COP is a disease generally associated with good prognoses, the majority of patients (73%) with COP manifest signs of remaining disease of interstitial lung disease pattern on follow-up CT scans. When lesions remain, they largely mimic the fibrotic NSIP pattern. Higher initial FVC and DL CO levels in patients with COP may predict complete resolution of parenchymal opacity on follow-up CT scans. Recurrence after corticosteroid treatment occurs in approximately 10% of patients. References 1. Davison AG, Heard BE, McAllister WA, Turner- Warwick ME. Cryptogenic organizing pneumonitis. Q J Med 1983; 52: American Thoracic Society/European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: Muller NL, Guerry-Force ML, Staples CA, et al. Differential diagnosis of bronchiolitis obliterans with organizing pneumonia and usual interstitial pneumonia: clinical, functional, and radiologic findings. Radiology 1987; 162: Lee KS, Kullnig P, Hartman TE, Muller NL. Cryptogenic organizing pneumonia: CT findings in 43 patients. AJR 1994; 162: Muller NL, Staples CA, Miller RR. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. AJR 1990; 154: Akira M, Yamamoto S, Sakatani M. Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR 1998; 170: Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier JF. The Groupe d Etudes et de Recherche sur les Maladles Orphelines Pulmonaires (GERM O P). Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am J Respir Crit Care Med 2000; 162: Cohen AJ, King TE Jr, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994; 149: Izumi T, Kitaichi M, Nishimura K, Nagai S. Bronchiolitis obliterans organizing pneumonia: clinical features and differential diagnosis. Chest 1992; 102: Shin KM, Lee KS, Chung MP, et al. Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study. Radiology 2008; 249: Cordier JF, Loire R, Brune J. Idiopathic bronchiolitis obliterans organizing pneumonia: definition of characteristic clinical profiles in a series of 16 patients. Chest 1989; 96: Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312: Logan PM, Miller RR, Muller NL. Cryptogenic organizing pneumonia in the immunocompromised patient: radiologic findings and follow-up in 12 patients. Can Assoc Radiol J 1995; 46: Yamamoto M, Ina Y, Kitaichi M, Harasawa M, Tamura M. Clinical features of BOOP in Japan. Chest 1992; 102:21S 25S 15. Barroso E, Hernandez L, Gil J, Garcia R, Aranda I, Romero S. Idiopathic organizing pneumonia: a relapsing disease: 19 years of experience in a hospital setting. Respiration 2007; 74: Park JS, Lee KS, Kim JS, et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195: Johkoh T, Muller NL, Colby TV, et al. Nonspecific interstitial pneumonia: correlation between thinsection CT findings and pathologic subgroups in 55 patients. Radiology 2002; 225: Travis WD, Hunninghake G, King TE, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008; 177: AJR:195, October 2010
Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus
Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Poster No.: C-1622 Congress: ECR 2012 Type: Scientific Exhibit Authors: C. Cordero Lares, E. Zorita
More informationDifferential diagnosis
Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential
More informationUsual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia: Serial Thin-Section CT Findings Correlated with Pulmonary Function
Usual Interstitial Pneumonia and Non-Specific Interstitial Pneumonia: Serial Thin-Section CT Findings Correlated with Pulmonary Function Yeon Joo Jeong, MD 1, 2 Kyung Soo Lee, MD 1 Nestor L. Muller, MD
More informationLiebow and Carrington's original classification of IIP
Liebow and Carrington's original classification of IIP-- 1969 Eric J. Stern MD University of Washington UIP Usual interstitial pneumonia DIP Desquamative interstitial pneumonia BIP Bronchiolitis obliterans
More informationFinancial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature
Financial disclosure I have no financial relationships to disclose. Douglas Johnson D.O. Cardiothoracic Imaging Gaston Radiology COMMON DIAGNOSES IN HRCT High Res Chest Anatomy Nomenclature HRCT Sampling
More informationImaging: how to recognise idiopathic pulmonary fibrosis
REVIEW IDIOPATHIC PULMONARY FIBROSIS Imaging: how to recognise idiopathic pulmonary fibrosis Anand Devaraj Affiliations: Dept of Radiology, St George s Hospital, London, UK. Correspondence: Anand Devaraj,
More informationKey words: CT scanners; interstitial lung diseases; polymyositis-dermatomyositis; x-ray
Nonspecific Interstitial Pneumonia Associated With Polymyositis and Dermatomyositis* Serial High-Resolution CT Findings and Functional Correlation Hiroaki Arakawa, MD; Hidehiro Yamada, MD; Yasuyuki Kurihara,
More informationT he diagnostic evaluation of a patient with
546 REVIEW SERIES Challenges in pulmonary fibrosis? 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias Michael B Gotway, Michelle M
More information4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs
Update in ILDs Diagnosis 101: Clinical Evaluation April 17, 2010 Jay H. Ryu, MD Mayo Clinic, Rochester MN Clinical Evaluation of ILD Outline General aspects of ILDs Classification of ILDs Clinical evaluation
More informationThe Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page
The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page 1135-1140 Role of High Resolution Computed Tomography in Diagnosis of Interstitial Lung Diseases in Patients with Collagen Diseases
More informationUsual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.
Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia Nitra and the Gangs. บทน ำและบทท ๓, ๑๐, ๑๒, ๑๓, ๑๔, ๑๕, ๑๗ Usual Interstitial Pneumonia (UIP) Most common & basic pathologic pattern
More informationProgress in Idiopathic Pulmonary Fibrosis
Progress in Idiopathic Pulmonary Fibrosis David A. Lynch, MB Disclosures Progress in Idiopathic Pulmonary Fibrosis David A Lynch, MB Consultant: t Research support: Perceptive Imaging Boehringer Ingelheim
More informationOutline Definition of Terms: Lexicon. Traction Bronchiectasis
HRCT OF IDIOPATHIC INTERSTITIAL PNEUMONIAS Disclosures Genentech, Inc. Speakers Bureau Tadashi Allen, MD University of Minnesota Assistant Professor Diagnostic Radiology 10/29/2016 Outline Definition of
More information11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective Radiology Pathology Clinical 1 Role of HRCT Diagnosis Fibrosis vs. inflammation Next step in management Response to treatment
More informationDiffuse Interstitial Lung Diseases: Is There Really Anything New?
: Is There Really Anything New? Sujal R. Desai, MBBS, MD ESTI SPEAKER SUNDAY Society of Thoracic Radiology San Antonio, Texas March 2014 Diffuse Interstitial Lung Disease The State of Play DILDs Is There
More informationINTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018
INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial
More informationCriteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP)
Criteria for confident HRCT diagnosis of usual interstitial pneumonia (UIP) Assem El Essawy (1) & Amr A. Nassef (٢) Abstract Identification of interstitial pneumonia (IP) was mainly based on histological
More informationHypothesis on the Evolution of Cavitary Lesions in Nontuberculous Mycobacterial Pulmonary Infection: Thin-Section CT and Histopathologic Correlation
CT of Nontuberculous Mycobacterial Pulmonary Infection Tae Sung Kim 1 Won-Jung Koh 2 Joungho Han 3 Myung Jin Chung 1 Ju Hyun Lee 1 Kyung Soo Lee 1 O Jung Kwon 2 Kim TS, Koh W-J, Han J, et al. Received
More informationThoracic lung involvement in rheumatoid arthritis: Findings on HRCT
Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Poster No.: C-2488 Congress: ECR 2015 Type: Educational Exhibit Authors: R. E. Correa Soto, M. J. Martín Sánchez, J. M. Fernandez 1 1
More informationHypersensitivity Pneumonitis: Spectrum of High-Resolution CT and Pathologic Findings
CT of Hypersensitivity Pneumonitis Chest Imaging Pictorial Essay C. Isabela S. Silva 1 ndrew Churg 2 Nestor L. Müller 1 Silva CIS, Churg, Müller NL Keywords: high-resolution CT, hypersensitivity pneumonitis,
More informationThin-Section CT Findings in 32 Immunocompromised Patients with Cytomegalovirus Pneumonia Who Do Not Have AIDS
Tomás Franquet 1,2 Kyung S. Lee 3 Nestor L. Müller 1 Received January 27, 2003; accepted after revision April 21, 2003. 1 Department of Radiology, Vancouver Hospital and Health Sciences Center and University
More informationCTD-related Lung Disease
13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of
More informationBronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias
Respiratory Medicine (2007) 101, 655 660 Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias Yon Ju Ryu a, Man Pyo Chung b,, Joungho Han c, Tae Sung Kim d, Kyung Soo Lee d, Eun-Mi Chun
More informationCombined pulmonary fibrosis and emphysema; prevalence and follow up among health-care personnel
Combined pulmonary fibrosis and emphysema; prevalence and follow up among health-care personnel Poster No.: C-0698 Congress: ECR 2013 Type: Scientific Exhibit Authors: K. Chae, G. Jin, S. Chon, Y. Lee;
More informationConnective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates
Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Maria Elena Vega, M.D Assistant Professor of Medicine Lewis Katz School of Medicine at Temple University Nothing to
More information5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective No, I am not a pulmonologist! Radiology Pathology Clinical 1 Everyone needs a CT Confidence in diagnosis Definitive HRCT +
More informationIdiopathic interstitial pneumonias (IIPs) are a group of
SYMPOSIA C. Isabela S. Silva, MD, PhD and Nestor L. Müller, MD, PhD Abstract: The idiopathic interstitial pneumonias (IIPs) are a group of diffuse parenchymal lung diseases of unknown etiology characterized
More informationDaria Manos RSNA 2016 RC 401. https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html
Daria Manos RSNA 2016 RC 401 https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html STEP1: Is this fibrotic lung disease? STEP 2: Is this a UIP pattern? If yes:
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Idiopathic Pulmonary Fibrosis Page 1 of 10 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Idiopathic Pulmonary Fibrosis (Esbriet /pirfenidone, Ofev /nintedanib)
More informationDiffuse interstitial lung diseases (DILDs) are a heterogeneous group of non-neoplastic, noninfectious
Focused Issue of This Month Diagnostic Approaches to Diffuse Interstitial Lung Diseases Dong Soon Kim, MD Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine E -
More informationImaging Small Airways Diseases: Not Just Air trapping. Eric J. Stern MD University of Washington
Imaging Small Airways Diseases: Not Just Air trapping Eric J. Stern MD University of Washington What we are discussing SAD classification SAD imaging with MDCT emphasis What is a small airway? Airway with
More informationDiagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines
Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Rebecca Keith, MD Assistant Professor, Division of Pulmonary and Critical Care Medicine National Jewish Health, Denver, CO Objectives
More informationSystemic lupus erythematosus (SLE): Pleuropulmonary Manifestations
08/30/10 09/26/10 Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations Camila Downey S. Universidad de Chile, School of Medicine, Year VII Harvard University, School of Medicine Sept 17,
More informationFocal Organizing Pneumonia on Surgical Lung Biopsy* Causes, Clinicoradiologic Features, and Outcomes
CHEST Focal Organizing Pneumonia on Surgical Lung Biopsy* Causes, Clinicoradiologic Features, and Outcomes Fabien Maldonado, MD; Craig E. Daniels, MD; Elizabeth A. Hoffman, MD; Eunhee S. Yi, MD; and Jay
More informationThe radiological differential diagnosis of the UIP pattern
5th International Conference on Idiopathic Pulmonary Fibrosis, Modena, 2015, June 12th The radiological differential diagnosis of the UIP pattern Simon Walsh King s College Hospital Foundation Trust London,
More informationRadiation Pneumonitis Joseph Junewick, MD FACR
Radiation Pneumonitis Joseph Junewick, MD FACR 03/19/2010 History 16 year old with history of relapsed stage IV-A Hodgkin disease. Prior pulmonary involvement was irradiated. Diagnosis Radiation Pneumonitis
More informationHRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution
Steps in High Resolution CT Diagnosis Pattern of abnormality Distribution of disease Associated findings Clinical history Tomás Franquet MD What is the diagnosis? Hospital de Sant Pau. Barcelona Secondary
More informationAcute and Chronic Lung Disease
KATHOLIEKE UNIVERSITEIT LEUVEN Faculty of Medicine Acute and Chronic Lung Disease W De Wever, JA Verschakelen Department of Radiology, University Hospitals Leuven, Belgium Clinical utility of HRCT To detect
More informationFollicular bronchiolitis in surgical lung biopsies: Clinical implications in 12 patients
Respiratory Medicine (2008) 102, 307 312 Follicular bronchiolitis in surgical lung biopsies: Clinical implications in 12 patients Michelle R. Aerni a, Robert Vassallo a,, Jeffrey L. Myers b, Rebecca M.
More informationCase 1: Question. 1.1 What is the main pattern of this HRCT? 1. Intralobular line 2. Groundglass opacity 3. Perilymphatic nodule
HRCT WORK SHOP Case 1 Case 1: Question 1.1 What is the main pattern of this HRCT? 1. Intralobular line 2. Groundglass opacity 3. Perilymphatic nodule Case 1: Question 1.2 What is the diagnosis? 1. Hypersensitivity
More informationImaging findings in Hypersensitivity Pneumonitis - a pictorical review.
Imaging findings in Hypersensitivity Pneumonitis - a pictorical review. Poster No.: C-1655 Congress: ECR 2014 Type: Educational Exhibit Authors: B. M. Araujo, A. F. S. Simões, M. S. C. Rodrigues, J. Pereira;
More informationThe crazy-paving pattern: A radiological-pathological correlated and illustrated overview
The crazy-paving pattern: A radiological-pathological correlated and illustrated overview Poster No.: C-0827 Congress: ECR 2010 Type: Educational Exhibit Topic: Chest Authors: W. F. M. De Wever, J. Coolen,
More informationNONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP
UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF () FOR PATHOLOGISTS Thomas V. Colby, M.D. Professor of Pathology (Emeritus) Mayo Clinic Arizona FINANCIAL DISCLOSURES NONE OVERVIEW IPF Radiologic Dx Pathologic
More informationIPF: Epidemiologia e stato dell arte
IPF: Epidemiologia e stato dell arte Clinical Classification Diffuse parenchimal lung diseases Exposure-related: - occupational - environmental - medication Desquamative interstitial pneumonia Idiopathic
More informationLung Allograft Dysfunction
Lung Allograft Dysfunction Carlos S. Restrepo M.D. Ameya Baxi M.D. Department of Radiology University of Texas Health San Antonio Disclaimer: We do not have any conflict of interest or financial gain to
More informationChanges in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation
Eur Respir J 2007; 29: 453 461 DOI: 10.1183/09031936.00015506 CopyrightßERS Journals Ltd 2007 Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after
More informationARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b,
Respiratory Medicine (2005) 99, 948 954 Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature
More informationInternational consensus statement on idiopathic pulmonary fibrosis
Eur Respir J 2001; 17: 163 167 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 PERSPECTIVE International consensus statement on idiopathic
More informationINVITED REVIEW SERIES: PULMONARY FIBROSIS SERIES EDITORS: MARTIN KOLB AND GERARD COX
INVITED REVIEW SERIES: PULMONARY FIBROSIS SERIES EDITORS: MARTIN KOLB AND GERARD COX Diagnosing fibrotic lung disease: When is high-resolution computed tomography sufficient to make a diagnosis of idiopathic
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Hunninghake GM, Hatabu H, Okajima Y, et al. MUC5B promoter
More informationComparison of CT findings between MDR-TB and XDR-TB
Comparison of CT findings between MDR-TB and XDR-TB Poster No.: C-0757 Congress: ECR 2017 Type: Authors: Keywords: DOI: Scientific Exhibit K. Yoon, H. Soohee; Changwon-si/KR Thorax, Lung, Respiratory system,
More informationNonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis
Original Article Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Xia Li 1, Chang Chen 2, Jinfu Xu 1, Jinming Liu 1, Xianghua
More informationManish Powari Regional Training Day 10/12/2014
Manish Powari Regional Training Day 10/12/2014 Large number of different types of Interstitial Lung Disease (ILD). Most are very rare Most patients present with one of a smaller number of commoner diseases
More informationPulmonary CT Findings of Visceral Larva Migrans due to Ascaris suum
Pulmonary CT Findings of Visceral Larva Migrans due to Ascaris suum Poster No.: E-0038 Congress: ESTI 2012 Type: Scientific Exhibit Authors: K. Honda, F. Okada, Y. Ando, A. Ono, S. Matsumoto, H. Mori;
More informationDiagnostic challenges in IPF
Medicine, Nursing and Health Sciences Diagnostic challenges in IPF Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University March 2015 Disclosures Consultancy fees from
More informationChallenges in the Diagnosis of Interstitial Lung Disease
Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification
More informationPulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment
Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,
More informationA Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco
A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Why it is important Definition/Classification
More informationARDS - a must know. Page 1 of 14
ARDS - a must know Poster No.: C-1683 Congress: ECR 2016 Type: Authors: Keywords: DOI: Educational Exhibit M. Cristian; Turda/RO Education and training, Edema, Acute, Localisation, Education, Digital radiography,
More informationTBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than
TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than PAP) BAL is not required as a diagnostic tool in patients
More informationCombined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases
CASE REPORT Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases Nobuhiko Nagata 1, Kentaro Watanabe 2, Michihiro Yoshimi 3, Hiroshi Okabayashi 4, Katsuo Sueishi 5, Kentaro
More informationComparison of CT Findings
Newly Detected Pulmonary Nontuberculous Mycobacterial Infection and Peripheral Lung Cancers in Patients During Follow-Up of Idiopathic Interstitial Pneumonia Comparison of CT Findings Sang Young Oh, MD,
More informationA case of a patient with IPF treated with nintedanib. Prof. Kreuter and Prof. Heussel
A case of a patient with IPF treated with nintedanib Prof. Kreuter and Prof. Heussel Case Overview This case describes the history of a patient with IPF who, at the time of diagnosis, had symptoms typical
More informationChallenges in the Diagnosis of Interstitial Lung Disease
Challenges in the Diagnosis of Interstitial Lung Disease Kirk D. Jones, MD UCSF Dept. of Pathology kirk.jones@ucsf.edu Overview New Classification of IIP Prior classification Modifications for new classification
More informationNon-neoplastic Lung Disease II
Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,
More informationIdiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping
Idiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping K. R. Flaherty Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor,
More informationTitle. CitationJapanese Journal of Ophthalmology, 50(6): Issue Date Doc URL. Rights. Type. File Information
Title Chronic panuveitis and scleritis in a patient with c Author(s)Saito, Wataru; Saito, Akari; Namba, Kenichi; Kase, S CitationJapanese Journal of Ophthalmology, 50(6): 558-561 Issue Date 2006 Doc URL
More informationIs it really honeycombing? Limitations and pitfalls in radiological diagnosis of honeycombing.
Is it really honeycombing? Limitations and pitfalls in radiological diagnosis of honeycombing. J. Arenas-Jiménez, E. García-Garrigós, M. Sirera-Matilla; M.C. Planells-Alduvin, F.I. Aranda* Hospital General
More informationUIP Possibile e Probabile
UIP Possibile e Probabile Sergio Harari U.O. di Pneumologia e UTIR Servizio di Emodinamica e Fisiopatologia Respiratoria Ospedale San Giuseppe - Milano Current definition of IPF IPF is a distinct type
More informationHow to identify interstitial pneumonias.
How to identify interstitial pneumonias. Poster No.: C-0804 Congress: ECR 2014 Type: Educational Exhibit Authors: S. claret loaiza, M. C. Cañete Moslero, R. Carreño Gonzalez, C. de la Torre; Malaga/ES
More informationPediatric High-Resolution Chest CT
Pediatric High-Resolution Chest CT Alan S. Brody, MD Professor of Radiology and Pediatrics Chief, Thoracic Imaging Cincinnati Children s s Hospital Cincinnati, Ohio, USA Pediatric High-Resolution CT Short
More informationA Review of Interstitial Lung Diseases
Outline A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Overview of diagnosis in ILD Why it is important Definition/Classification
More informationPathologic Assessment of Interstitial Lung Disease
Pathologic Assessment of Interstitial Lung Disease Dry and itchy? It could be eczema or fungal infection. We don t need to worry, the drugs aren t that dangerous. Kirk D. Jones, MD UCSF Dept. of Pathology
More informationWith recent advances in diagnostic imaging technologies,
ORIGINAL ARTICLE Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Kwhanmien Kim, MD,* Young Mog
More informationSmoking-related Interstitial Lung Diseases: High-Resolution CT Findings
Smoking-related Interstitial Lung Diseases: High-Resolution CT Findings Poster No.: C-2358 Congress: ECR 2013 Type: Educational Exhibit Authors: V. Cuartero Revilla, M. Nogueras Carrasco, P. Olmedilla
More informationThe Imaging Analysis of Pulmonary Sarcodiosis
www.cancercellresearch.org ISSN: 2161-2609 Article The Imaging Analysis of Pulmonary Sarcodiosis Xin He, Chuanyu Zhang* Department of Radiology, Affiliated Hospital of Qingdao University, Qingdao, China
More informationPrognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis JULIE A. BJORAKER, JAY H. RYU, MARK K. EDWIN, JEFFREY L. MYERS, HENRY D. TAZELAAR, DARRELL R. SCHROEDER, and KENNETH
More informationAugust 2018 Imaging Case of the Month: Dyspnea in a 55-Year-Old Smoker. Michael B. Gotway, MD
August 2018 Imaging Case of the Month: Dyspnea in a 55-Year-Old Smoker Michael B. Gotway, MD Department of Radiology Mayo Clinic Arizona Scottsdale, AZ USA Clinical History: A 55 year old woman presented
More informationSeptember 2014 Imaging Case of the Month. Michael B. Gotway, MD. Department of Radiology Mayo Clinic Arizona Scottsdale, AZ
September 2014 Imaging Case of the Month Michael B. Gotway, MD Department of Radiology Mayo Clinic Arizona Scottsdale, AZ Clinical History: A 57-year-old non-smoking woman presented to her physician as
More informationTypical and Atypical Manifestations of Intrathoracic Sarcoidosis
Typical and typical Manifestations of Intrathoracic Sarcoidosis Hyun Jin Park, MD 1 Jung Im Jung, MD 1 Myung Hee Chung, MD 1 Sun Wha Song, MD 1 Hyo Lim Kim, MD 1 Jun Hyun aik, MD 1 Dae Hee Han, MD 1 Ki
More informationJune 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2
June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 Departments of Pulmonary Medicine 1 and Laboratory Medicine and Pathology 2 Mayo Clinic
More informationMiddle East Respiratory Syndrome-Coronavirus Infection: A Case Report of Serial Computed Tomographic Findings in a Young Male Patient
Case Report Thoracic Imaging http://dx.doi.org/10.3348/kjr.2016.17.1.166 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2016;17(1):166-170 Middle East Respiratory Syndrome-Coronavirus Infection: A Case
More informationPulmonary manifestations of Rheumatoid Arthritis: what is there waiting to be found?
Pulmonary manifestations of Rheumatoid Arthritis: what is there waiting to be found? Poster No.: C-1795 Congress: ECR 2015 Type: Educational Exhibit Authors: M. S. C. Rodrigues, R. Correia, A. Carvalho,
More informationLung CT: Part 2, The Interstitial Pneumonias Clinical, Histologic, and CT Manifestations
Integrative Imaging Review Ferguson and Berkowitz CT of Interstitial Pneumonia Integrative Imaging Review CME SAM Lung CT FOCUS ON: Emma C. Ferguson 1 Eugene A. Berkowitz 2 Ferguson EC, Berkowitz EA Keywords:
More informationDIAGNOSTIC NOTE TEMPLATE
DIAGNOSTIC NOTE TEMPLATE SOAP NOTE TEMPLATE WHEN CONSIDERING A DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS (IPF) CHIEF COMPLAINT HISTORY OF PRESENT ILLNESS Consider IPF as possible diagnosis if any of the
More informationIPF - Inquadramento clinico
IPF - Inquadramento clinico Sergio Harari Unità Operativa di Pneumologia UTIR Servizio di Fisiopat. Resp. e Emodinamica Polmonare Ospedale S. Giuseppe, Milano Clinical Classification Diffuse parenchimal
More informationCase Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco
Case Presentations in ILD Harold R. Collard, MD Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Definition/Classification High-resolution CT scan Multidisciplinary
More informationPulmonary Sarcoidosis - Radiological Evaluation
Original Research Article Pulmonary Sarcoidosis - Radiological Evaluation Jayesh Shah 1, Darshan Shah 2*, C. Raychaudhuri 3 1 Associate Professor, 2 1 st Year Resident, 3 Professor and HOD Radiology Department,
More informationTB Radiology for Nurses Garold O. Minns, MD
TB Nurse Case Management Salina, Kansas March 31-April 1, 2010 TB Radiology for Nurses Garold O. Minns, MD April 1, 2010 TB Radiology for Nurses Highway Patrol Training Center Salina, KS April 1, 2010
More informationCT Findings in the Elderly Lung
CT Findings in the Elderly Lung Poster No.: C-2498 Congress: ECR 2015 Type: Educational Exhibit Authors: P. Ananias, R. Coelho, H. M. R. Marques, O. Fernandes, M. Simões, L. Figueiredo; Lisbon/PT Keywords:
More informationCT Findings of Surgically Resected Pleomorphic Carcinoma of the Lung in 30 Patients
Kim et al. CT of Pleomorphic Carcinoma of the Lung Chest Imaging Clinical Observations Tae Sung Kim 1 Joungho Han 2 Kyung Soo Lee 1 Yeon Joo Jeong 1 Seo Hyun Kwak 1 Hong Sik Byun 1 Myung Jin Chung 1 Hojoong
More informationPulmonary Complications of Antineoplastic Agents : Era of Targeted Therapy
Pulmonary Complications of Antineoplastic Agents : Era of Targeted Therapy Poster No.: C-1230 Congress: ECR 2013 Type: Educational Exhibit Authors: H. Y. Kim, J. H. Hwang, Y.-W. Chang, J. Y. Moon; Seoul/KR
More information10/17/2016. Nuts and Bolts of Thoracic Radiology. Objectives. Techniques
Nuts and Bolts of Thoracic Radiology October 20, 2016 Carleen Risaliti Objectives Understand the basics of chest radiograph Develop a system for interpreting chest radiographs Correctly identify thoracic
More informationOctober 2012 Imaging Case of the Month. Michael B. Gotway, MD Associate Editor Imaging. Department of Radiology Mayo Clinic Arizona Scottsdale, AZ
October 2012 Imaging Case of the Month Michael B. Gotway, MD Associate Editor Imaging Department of Radiology Mayo Clinic Arizona Scottsdale, AZ Clinical History: A 65-year-old non-smoking woman presented
More informationHYPERSENSITIVITY PNEUMONITIS
HYPERSENSITIVITY PNEUMONITIS A preventable fibrosis MOSAVIR ANSARIE MB., FCCP INTERSTITIAL LUNG DISEASES A heterogeneous group of non infectious, non malignant diffuse parenchymal disorders of the lower
More informationComparison of High-resolution CT Findings between Miliary Metastases and Miliary Tuberculosis 1
Comparison of High-resolution CT Findings between Miliary Metastases and Miliary Tuberculosis 1 Chan Sung Kim, M.D., Ki-Nam Lee, M.D., Jin Hwa Lee, M.D. Purpose: To compare the findings of high-resolution
More informationCardiopulmonary Imaging Original Research
Cardiopulmonary Imaging Original Research Song et al. CT After Stem Cell Transplant Cardiopulmonary Imaging Original Research Inyoung Song 1 Chin A Yi 1 Joungho Han 2 Dong Hwan Kim 3 Kyung Soo Lee 1 Tae
More informationRadiologic Approach to Smoking Related Interstitial Lung Disease
Radiologic Approach to Smoking Related Interstitial Lung Disease Poster No.: C-1854 Congress: ECR 2013 Type: Educational Exhibit Authors: K.-N. Lee, J.-Y. Han, E.-J. Kang, J. Kang; Busan/KR Keywords: Toxicity,
More informationPULMONARY TUBERCULOSIS RADIOLOGY
PULMONARY TUBERCULOSIS RADIOLOGY RADIOLOGICAL MODALITIES Medical radiophotography Radiography Fluoroscopy Linear (conventional) tomography Computed tomography Pulmonary angiography, bronchography Ultrasonography,
More information